Zhou T J, Chiu J W, White P F, Forestner J E, Murphy M T
Department of Anesthesiology and Pain Management, University of Texas, Southwestern Medical Center at Dallas, 75239-9068, USA.
Acta Anaesthesiol Scand. 2001 Feb;45(2):246-9.
The use of volatile anesthetics for maintenance of anesthesia can enhance the action of non-depolarizing muscle relaxants and interfere with the reversal of neuromuscular blockade. In this study, we studied the antagonism of rocuronium with edrophonium-atropine during propofol- versus sevoflurane-based anesthesia.
Following induction of anesthesia with propofol (2-2.5 mg kg(-1), i.v.) and fentanyl (1-2 microg kg(-1) i.v.), rocuronium 0.6 mg kg(-1) i.v. was administered to facilitate tracheal intubation. Patients were then randomized to receive either a propofol infusion (100 microg kg(-1) min(-1)) or sevoflurane (1.0%, end-tidal) in combination with nitrous oxide 66% for maintenance of anesthesia. Neuromuscular blockade was monitored using electromyography at the wrist, and reversed with edrophonium 1.0 mg kg(-1) and atropine 0.015 mg kg(-1) when the first twitch hight (T1) of the train-of-four (TOF) stimulation recovered to 25% of the baseline value. Anesthetic maintenance with propofol or sevoflurane was continued following reversal until a TOF ratio of 0.7 was attained.
The clinical duration of action (i.e., time to 25% T1 recovery) was similar during both propofol- (39.3+/-14.6 min) and sevoflurane-based (48.1+/-19.7 min) anesthesia. However, the reversal time from 25% T1 to TOF ratio of 0.7 was significantly longer with sevoflurane [Median 2.8 (range 0.5-18.8) min] compared with propofol [1.5 (0.75-3) min] (P<0.05).
We conclude that the clinical duration of action after a single dose of rocuronium, 0.6 mg kg(-1) i.v., was similar during both propofol- and sevoflurane-based anesthesia. However, the reversal of rocuronium-induced residual blockade was slower and more variable in the presence of sevoflurane.
使用挥发性麻醉剂维持麻醉可增强非去极化肌松药的作用,并干扰神经肌肉阻滞的逆转。在本研究中,我们研究了在丙泊酚麻醉和七氟醚麻醉期间,依酚氯铵 - 阿托品对罗库溴铵的拮抗作用。
用丙泊酚(2 - 2.5 mg·kg⁻¹,静脉注射)和芬太尼(1 - 2 μg·kg⁻¹,静脉注射)诱导麻醉后,静脉注射0.6 mg·kg⁻¹罗库溴铵以利于气管插管。然后将患者随机分为两组,一组接受丙泊酚输注(100 μg·kg⁻¹·min⁻¹),另一组接受七氟醚(呼气末浓度1.0%)联合66%氧化亚氮维持麻醉。使用腕部肌电图监测神经肌肉阻滞情况,当四个成串刺激(TOF)的第一个肌颤搐高度(T1)恢复到基线值的25%时,用1.0 mg·kg⁻¹依酚氯铵和0.015 mg·kg⁻¹阿托品进行逆转。逆转后继续用丙泊酚或七氟醚维持麻醉,直至TOF比值达到0.7。
丙泊酚麻醉(39.3±14.6分钟)和七氟醚麻醉(48.1±19.7分钟)期间,罗库溴铵的临床作用持续时间(即T1恢复到25%的时间)相似。然而,与丙泊酚组[1.5(0.75 - 3)分钟]相比,七氟醚组从T1恢复到25%至TOF比值达到0.7的逆转时间明显更长[中位数2.8(范围0.5 - 18.8)分钟](P<0.05)。
我们得出结论,静脉注射0.6 mg·kg⁻¹罗库溴铵后,丙泊酚麻醉和七氟醚麻醉期间的临床作用持续时间相似。然而,在七氟醚存在的情况下,罗库溴铵诱导的残余阻滞的逆转较慢且变异性更大。